Advertise With Us

The EMBO Journal

The EMBO Journal publishes papers describing original research of broad general interest in molecular and cell biology - a particular emphasis is placed on molecular mechanism and physiological relevance.

 

The journal encourages and publishes articles that report novel findings of wide biological significance in the areas of:

  • Ageing
  • Autophagy
  • Cancer
  • Cell Adhesion, Polarity & Cytoskeleton
  • Cell Cycle
  • Cell Death
  • Developmental Biology
  • DNA Replication, Repair & Recombination
  • Chromatin, Epigenetics & Genomics
  • Immunology
  • Membrane & Intracellular Transport
  • Metabolism
  • Microbiology, Virology & Host Pathogen Interaction
  • Molecular Biology of Disease
  • Neuroscience
  • Plant Biology
  • Post-translational Modifications, Proteolysis & Proteomics
  • RNA Biology
  • Signal Transduction
  • Stem Cells
  • Structural Biology
  • Systems, Chemical & Computational Biology
  • Transcription
  • Protein Biosynthesis & Quality Control
  • Vascular Biology

Bionic ID: 645950

Advertising Options

Below are The EMBO Journal advertising placement options to consider in your media planning and media buying.

  • E-Newsletter Advertising

    • E-Newsletters
  • Magazine Advertising

    • 1/2 page
    • 1/3 page - 1/3 page
    • 1/4 page - 1/4 page
    • 1/6 page - 1/6 page
    • Full page - Full page
  • Social Advertising

    • Facebook Post
    • LinkedIn Post
    • Twitter Post
  • Video Advertising

    • Youtube Post
  • Online Display Advertising

    • 300x250 - Medium Rectangle
    • 300x600 - Half Page
    • 728x90 - Leaderboard

Learn More

To learn more about the The EMBO Journal program, submit a request for information. Your request will be sent immediately to the John Wiley & Sons ad sales team.

Place an Order

To place an order, contact The EMBO Journal or order electronically through Bionic Media Buying Software using ID 645950.

© Copyright 2013-2022 NextMark, Inc. d/b/a Bionic Advertising Systems. All Rights Reserved. Terms of Use.